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A
mAbstract
Background: Heliox has a lower density and higher diffusion capacity compared to
oxygen-in-air. We hypothesized that heliox ventilation allows for a reduction in
minute volume ventilation and inspiratory pressures needed for adequate gas
exchange in an animal model of an acute lung injury.
Methods: After intratracheal instillation of lipopolysaccharide (10 mg/kg), adult rats
were randomized to ventilation with either a gas mixture of helium/oxygen (50:50%)
or oxygen/air (50:50%). They were mechanically ventilated according to the ARDSnet
recommendations with tidal volumes of 6 ml/kg and monitored with a
pneumotachometer. Bronchoalveolar lavage fluid was analyzed for markers of lung
injury, and embedded lung sections were histologically scored for lung injury.
Results: Heliox limited the increase in driving pressures needed to achieve preset
tidal volumes, with a concomitant decrease in loss of compliance. Heliox did neither
allow for reduced minute volume ventilation in this model nor improve gas
exchange. Also, heliox did not reduce lung injury.
Conclusions: Heliox modestly improved respiratory mechanics but did not improve
lung injury in this rat model of acute respiratory distress syndrome.
Keywords: Intensive care medicine; Heliox; Mechanical ventilation; ARDS;
Animal modelBackground
Obstructed airways with increased airway resistance and high inspiratory pressures
needed for adequate gas exchange are common features in acute respiratory distress
syndrome (ARDS) [1-3]. A limited tidal volume ventilation of 6 ml/kg is proven to be
beneficial in ARDS [4]. However, application of limited tidal volume ventilation can
often not be achieved in ARDS because of hypoxemia and acidosis [5,6]. Also, applica-
tion of relatively low plateau pressures and driving pressures can already be harmful
[7,8]. Thereby, mechanical ventilation may aggravate ARDS, the extent of which is af-
fected by the intensity of ventilation. In ARDS, higher minute volumes are needed to
compensate for increased oxygen demand and carbon dioxide production, increasing
the risk of additional injury by mechanical ventilation. Therefore, in ARDS, adjunctive
therapies which allow for less invasive ventilation are worth exploring.
Helium is an inert noble gas with a lower density compared to nitrogen. Thereby,
mechanical ventilation using a gas mixture of oxygen and helium (heliox) can reduce2014 Beurskens et al; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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ables a reduction in the work of breathing in patients with obstructed airflow due to in-
creased airway resistance during exacerbations of asthma and COPD [10]. Another
important feature of heliox is the increased diffusion of CO2 compared to air [9]. Con-
sequently, heliox decreases inspiratory pressures required to establish a set gas flow
and to enable gas exchange in distant alveoli [11,12].
The use of heliox has been evaluated in pediatric animal models of ARDS induced by
oleic acid or saline [13-15], showing that heliox ventilation improved gas exchange du-
ring high-frequency oscillatory ventilation. We recently showed that heliox improves
CO2 removal and decreases driving pressures in patients who are mechanically venti-
lated according to the recommended protective strategy, as well as in an animal model
of lung injury inflicted by high tidal volume ventilation [16,17].
In this study, we investigated the effects of heliox in an adult lung injury model. We hy-
pothesized that the use of heliox reduces minute volume ventilation and inspiratory pres-
sures with improved compliance. Furthermore, we hypothesized that the use of heliox
facilitates CO2 elimination during protective mechanical ventilation. Although without a
clear mechanism known, heliox showed anti-inflammatory effects in ARDS models in
previous studies [14,18], so the effect on the inflammatory response was also investigated.
Methods
Animal study design
The animal care and use committee of the Academic Medical Center, University of
Amsterdam, Netherlands approved this study. Animal procedures were carried out in
compliance with Institutional Standards for Use of Animal Laboratory Animals.
Induction of lung injury, anesthesia, instrumentation, and mechanical ventilation
Male Sprague–Dawley rats (Harlan, The Hague, The Netherlands), weighing 350 to
400 g, were randomized into four experimental groups. Two groups were anesthetized
using a transoral miniature nebulizer under light anesthesia (97% oxygen with 3% iso-
flurane) and intratracheally instilled with 1 mg/kg of Escherichia coli lipopolysaccharide
(LPS) (L4131, 7.5 mg/kg, Sigma Aldrich, Steinheim, Germany). Control groups received
no instillation. Two hours after LPS instillation, the animals were anesthetized by in-
traperitoneal injection of 90 mg/kg ketamine (Nimatek®; Eurovet Animal Health BV,
Bladel, the Netherlands), 0.125 mg/kg dexmedetomidine (Dexdomitor®; Orion Pharma,
Espoo, Finland), and 0.05 mg/kg atropine (atropine sulfate; Centrafarm BV, Etten-Leur,
the Netherlands). Via a tail vein Venflon cannula, anesthesia was maintained by infu-
sion of 10 mg/ml ketamine at 2.7 ml/h. A solution of saline and 4.2 mg/ml bicarbonate
(Fresenius Kabi Nederland BV, Hertogenbosch, the Netherlands) was administered at
2.5 ml/h.
A tracheotomy was performed and a metal cannula was inserted into the trachea.
Two sutures were placed around the exposed part of the trachea into which the can-
nula was tied down thoroughly. The cannula was then connected to a ventilator (Servo
900C, Siemens, Upplands Vasby, Sweden). The ventilators were calibrated for the heliox
gas mixture according to the instruction of the manufacturer using a pressure reduc-
tion valve to allow the high-pressure of the heliox tank to be reduced to safe and usable
pressures for ventilation (Linde Gas Therapeutics, Eindhoven, the Netherlands).
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saline (1:1,000)-filled catheter into the right carotid artery (Braun, Melsungen, Germany)
that was connected to a monitor (Siemens SC900, Danvers, MA, USA). Temperature was
monitored rectally (Ama-digit ad 15th, Amarell, Kreuzwertheim, Germany) and main-
tained at 37°C by a thermo mattress.
The rats were ventilated in a pressure-controlled mode for 4 h, with either heliox
(technical gas 50% oxygen; 50% helium; blended by Linde Gas Therapeutics) or 50%
oxygen-in-air gas mixture. In total, 32 animals were studied of which 16 received heliox
(8 LPS, 8 healthy controls) and 16 received 50% oxygen-in-air gas mixture (8 LPS,
8 healthy controls).
Lung protective (LP) ventilation was maintained, according to a fixed protocol, by ap-
plying 6 ml/kg and 5 cm H2O positive end-expiratory pressure (PEEP). FiO2 was set at
50% with an inspiration to expiration ratio of 1:2 and adjustment of respiratory rate to
maintain arterial PaCO2 within 4.5 to 6.0 kPa, according to hourly drawn arterial blood
gases (RAPIDlab 865 blood gas analyzer, Bayern, Mijdrecht, the Netherlands).
Tidal volumes were strictly maintained using a pneumotachometer (Hugo Sachs
Elektronik, Harvard apparatus, March-Hugstetten, Germany) specific for rats. The
pneumotachometer is a transducer for airflow measurement, placed between the metal
cannula and the ventilator. For both heliox and oxygen ventilation, the pneumotach-
ometer was calibrated using a 1-ml syringe according to the manufacturer's instruction.
Tidal volumes were recorded using respiration software (HSE-BDAS basic data acquisi-
tion, Harvard apparatus, March-Hugstetten, Germany) and displayed on a computer
screen throughout the whole experiment. We set a pressure controlled ventilation mode
and started with an inspiratory pressure of 15 cm H2O. The tidal volume was targeted by
adjusting the inspiratory pressure [17,19-21].
The inspiratory pressures were recorded every hour. The driving pressure was calcu-
lated by inspiratory pressure minus PEEP. Compliance was calculated by dividing the
tidal volume per kilogram by the driving pressure. Minute volume was calculated in
milliliter per minute by multiplying respiratory rate with the measured tidal volume.
Inflammation measurements
After 4 h of mechanical ventilation, the rats were bled and plasma was centrifuged at
1,800 × g for 10 min at 4°C. The lungs were removed en bloc and the right lung was li-
gated. A bronchoalveolar lavage was done by flushing the left lung three times with
2.0 ml NaCl, yielding approximately 5.5 to 6.0 ml of bronchoalveolar lavage fluid
(BALF).
In BALF, the cells were counted using a hematocytometer (Z2 Coulter Particle
Counter, Beckman Coulter Corporation; Hialeah, Florida, USA). After centrifugation
of BALF (300 × g for 10 min at 4°C), protein levels were measured (Oz Biosciences,
Marseille, France) and levels of interleukin (IL)-1β, IL-6, cytokine-induced neutrophil
chemoattractant 3 (CINC-3), and tumor necrosis factor alpha (TNF-α) were deter-
mined by ELISA in BALF and blood, according to instructions of the manufacturer
(R&D Systems, Abingdon, UK).
The upper lobe of the right lung was fixed in 1% buffered formaldehyde and subse-
quently embedded in paraffin and afterwards cut into 5-μm-thick sections. The lung
sections were fixed on glass slides and stained with hematoxylin and eosin and were
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ology score. This score consists of several parameters, including interstitial inflamma-
tion, endothelialitis, edema, bronchitis, thrombus, and pleuritis. All parameters were
scored on a scale of 0 to 4: 0 for normal lungs, 1 for <25% lung involvement, 2 for 25%
to 50% involvement, 3 for 50% to 75% involvement, and 4 for >75% lung involvement.
The total histology score was calculated as the sum score of these parameters, with a
maximum of 24. Furthermore, the pathologist was asked to choose one representative
illustration per group.
Statistical analysis
To compare time points (T = 0 vs. T = 4) within the same subject, a paired t test with
Bonferroni correction was used if data were normally distributed, or Wilcoxon signed
rank test in case of non-normal distribution. The effect of heliox versus oxygen-in-air
at specific time points was compared using a one-way ANOVA or Kruskal-Wallis test,
with either a Bonferroni's or Dunn's multiple comparison test, depending on the dis-
tribution of the data. Statistical significance was considered to be at P < 0.05 or at
P < 0.0125 after Bonferroni correction. Data are expressed as mean ± SD.
Results
All animals survived our experimental protocol. In animals receiving LPS, the mean ar-
terial pressure dropped over time (162 ± 19 to 128 ± 18 mmHg), whereas it remained
constant in the healthy controls. Heliox did not affect blood pressure or heart rate
compared to the oxygen-in-air-ventilated animals.
LPS induced acute lung injury
The instillation of LPS intratracheally resulted in a sufficient model of acute lung in-
jury, based on the guidelines described by the American Thoracic Society [22]. The
inflammatory response, one of the main features that characterize acute lung injury
in animal models, was evidenced by increased pulmonary cell influx in the BALF
(Figure 1A) and an increase in BALF cytokine levels of IL-1β, IL-6, TNF-α, and
CINC-3 (Figure 1C,D,E,F). The protein levels in BALF were not significantly different due
to a large variation (Figure 1B). Another important marker of lung injury in animals is the
histological evidence of tissue injury, which in our study is measured by the total histo-
pathology and which also increased due to LPS instillation (Figure 2). The pictures,
chosen by the pathologist, show a representative example of each intervention group,
showing interstitial inflammation, endothelialitis, edema, bronchitis, and pleuritis pro-
duced by the intratracheal LPS instillation.
The gas exchange at baseline and after 4 h of lung protective mechanical ventilation
with heliox or oxygen-in-air was also affected by LPS instillation. Baseline pH showed a
significant decrease with a concomitant increase in PaCO2 levels in LPS-challenged
animals compared to healthy controls (Table 1). These differences in gas exchange
disappeared during the experiment due to adjustments in respiratory rates. The ap-
plied respiratory rate needed to keep PaCO2 within predefined limits (4.5 to 6.0 kPa)
increased during mechanical ventilation in both LPS-treated groups, yielding an in-
creased percentage of change in minute volume ventilation versus the baseline measure-
ment (Figure 3A). Inspiratory pressures applied to target tidal volumes of 6 ml/kg were
Figure 1 Inflammatory parameters in an animal model of LPS-induced lung injury and healthy
controls. The animals were ventilated with heliox or oxygen-in-air (N = 8 per group). (A) Cell count.
(B) Protein levels. (C) IL-1β levels. (D) IL-6 levels. (E) TNF-α levels. (F) CINC-3 levels in BALF. Healthy animals
are marked by open dots and LPS animals by black dots. Data are presented as mean ± SD. *P < 0.05;
**P < 0.01; ***P < 0.001.
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sures in LPS-treated animals compared to healthy controls, with a significant in-
crease in the animals ventilated with oxygen only (Figure 3B,C). A concomitant decrease
in percentage change of compliance was seen in LPS-treated animals compared to healthy
controls, with again a significant increase in the animals ventilated with oxygen
(Figure 3D).
Effects of heliox
Heliox did not result in a reduction of inflammatory parameters when compared to the
oxygen-in-air ventilation. No effect was seen in the pulmonary neutrophil influx, pro-
tein, or cytokine levels in BALF (Figure 1A,B,C,D,E,F) or in the total histology score in
the lung (Figure 2). Also, use of heliox did not alter gas exchange (Table 1). Comparing
the change versus baseline, heliox did not influence minute volume ventilation needed
for adequate gas exchange compared to oxygen-in-air ventilation (Figure 3A). HelioxFigure 2 Total histology score in an animal model of LPS-induced lung injury and healthy controls.
The model was ventilated with heliox or oxygen-in-air (N = 8 per group). Healthy animals are marked by
open dots and LPS animals by black dots. Data are mean ± SD. *P < 0.05; **P < 0.01.
Table 1 Gas exchange in an animal model of LPS–induced lung; ventilated with heliox or
oxygen-in-air
Time (h) Healthy LPS
Oxygen-in-air Heliox Oxygen-in-air Heliox
pH 0 7.44 ± 0.04 7.42 ± 0.03 7.35 ± 0.05a 7.34 ± 0.08b
4 7.33 ± 0.04c 7.36 ± 0.03d 7.30 ± 0.06 7.30 ± 0.08
pCO2 (kPa) 0 4.38 ± 0.7 4.86 ± 0.6 5.78 ± 0.6
a 6.10 ± 1.4b
4 4.99 ± 0.4 5.81 ± 0.9 5.84 ± 0.77 5.75 ± 1.29
pO2 (kPa) 0 34.2 ± 1.8 31.7 ± 1.5 33.2 ± 1.7 32.3 ± 3.3
4 31.7 ± 2.5 30.8 ± 2.8 28.5 ± 3.9 28.8 ± 3.4
aOxygen-in-air LPS T = 0 vs. oxygen-in-air healthy T = 0, significant after Bonferroni's multiple comparison test (P < 0.01);
bHeliox LPS T = 0 vs. heliox healthy T = 0, significant after Bonferroni's multiple comparison test (P < 0.01); cOxygen-in-air
healthy T = 0 vs. oxygen-in-air healthy T = 4, significant after Bonferroni correction (P < 0.0125); dHeliox healthy T = 0 vs.
heliox healthy T = 4, significant after Bonferroni correction (P < 0.0125). Data are presented as mean ± SD. N = 8 per group.
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baseline needed to generate tidal volumes of 6 ml/kg in LPS-treated animals compared
to oxygen-in-air (Figure 3B,C). Concomitantly, the relative decrease in compliance in
LPS-treated animals was abrogated with heliox ventilation versus oxygen-in-air ventila-
tion (Figure 3D).
Discussion
In this animal model of induced acute lung injury due to LPS instillation, heliox ab-
rogated the increase in inspiratory and driving pressures needed to target preset tidal
volumes over time. Furthermore, heliox diminished the decrease in compliance com-
pared to baseline in LPS-treated animals. In contrast to our hypothesis, heliox did notFigure 3 Ventilatory parameters in an animal model of LPS–induced lung injury; changes versus
baseline. (A) Minute volume ventilation (ml/min), (B) inspiratory pressures (cm H2O), (C) driving pressures
(cm H2O), and (D) compliance (μl/cm H2O) in an animal model of LPS-induced lung injury and healthy con-
trols, ventilated with heliox or oxygen-in-air (N = 8 per group). Healthy animals are marked by open dots
and LPS animals by black dots. Data are presented as mean ± SD. *P < 0.05; **P < 0.01.
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ventilation. Moreover, heliox ventilation showed no effect on neither gas exchange
or on lung inflammation. Thereby, our results are somewhat in contrast to studies
investigating heliox ventilation in pediatric models as well as to findings in our
own animal model of ventilator-induced lung injury, where heliox improved CO2
removal [13-17].
There may be several explanations for the absence of a beneficial effect of heliox in
our model. Within our study design, we strictly regulated tidal volumes at 6 ml/kg. This
study design was chosen to reduce confounders, influencing our results. With this de-
sign, we believe that any measured effect of heliox on lung injury could be ascribed to
heliox only and not to a difference in tidal volumes. This distinction is important, be-
cause as a result of a more laminar flow pattern compared to oxygen-in-air ventilation,
the mechanism by which heliox improves CO2 removal might be by an increased tidal
volume delivery. In line with this, it was shown that during high-frequency oscillatory
ventilation in an animal ARDS model, heliox did not alter gas exchange if tidal volume
was kept constant [23]. If the findings would also be applicable during protective mech-
anical ventilation, based on the characteristics of heliox, we hypothesized a decrease in
inspiratory pressures needed to generate a set tidal volume, as found before [12]. How-
ever, our effects on inspiratory and driving pressures, as well as the compliance, were
only modest. Since we cannot exclude that heliox may be beneficial by allowing a fur-
ther reduction of tidal volumes, which was shown before to increase protection in
ARDS [24-26], the choice for strictly keeping tidal volumes at 6 ml/kg in these experi-
ments limits the interpretation of our results.
An alternative explanation for the differences with previous studies may be related to
differences in ventilation modes. The previous studies that showed a beneficial effect of
heliox were all performed in pediatric animal models, mostly during high-frequency os-
cillatory ventilation [13-15]. This same mode was also used in infants, showing a de-
creased airway resistance during heliox ventilation [27].
Differences may also relate to the underlying disease state. Whereas airway obstruc-
tion is present in our model of acute lung injury, the severity of airway obstruction is
far less compared to asthma, respiratory syncytial virus, or other disease states in which
hyper-reactivity of bronchi plays an important role [27-29]. In line with this, in a test
lung, the effect of heliox on reducing the inspiratory effort was shown to be dependent
on the kind of obstruction and severity [30]. Our model may also have been a too mild
model of lung injury, in which beneficial effects may be hard to tease out. However,
our model is clinically relevant and represents the most important parameters of acute
lung injury in animals [22].
The anti-inflammatory effects of heliox, previously reported in ARDS models [14,18],
could not be reproduced in our model. A clear mechanism on how heliox can affect
lung injury markers and histology scoring is not known; however, in healthy volunteers
helium resulted in an attenuated expression of inflammatory cell surface markers on
leukocytes and platelets in blood [31]. It is postulated that the influence of helium
might be via the cell-mediated immunity [32]. Furthermore, ventilation with heliox
might lower shear stress and barotraumas and therefore have an anti-inflammatory ef-
fect [14]. However, our results indicate that there is no direct anti-inflammatory effect
due to heliox ventilation.
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Heliox modestly limited the increase in inspiratory and driving pressures applied to tar-
get preset tidal volumes, with a concomitant restraint of the reduced compliance between
LPS-treated animals and healthy controls. However, heliox ventilation did neither allow
for lower minute volume ventilation nor did it have an effect on gas exchange, lung in-
flammation, or lung damage in an animal model of acute lung injury.
Competing interest
All authors declare no financial or other potential competing interest.
Authors’ contributions
CB, HA, and NJ designed the animal study. CB, HA, and FdB executed the study-protocol and collected the data. JR
scored the lung sections and calculated the total histology score of the lung. CB and NJ analyzed the data and wrote
the first draft of the manuscript; all authors contributed to the final version. All authors read and approved the final
manuscript.
Acknowledgements
NWO ZonMW Clinical Fellowship was granted to Dr. NPJ (project number 90700269).
Author details
1Laboratory of Experimental Intensive Care and Anaesthesiology, Academic Medical Center, University of Amsterdam,
Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands. 2Department of Intensive Care, Academic Medical Center,
University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands. 3Department of Pathology, Academic
Medical Center, University of Amsterdam, Amsterdam 1012 WX, the Netherlands.
Received: 23 January 2014 Accepted: 24 January 2014
Published: 6 February 2014
References
1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE, Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (2005) Acute
respiratory distress in adults. The Lancet 290(7511):319–323
2. Wright PE, Bernard GR (1989) The role of airflow resistance in patients with the adult respiratory distress
syndrome. Am Rev Respir Dis 139(5):1169–1174
3. Pelosi P, Cereda M, Foti G, Giacomini M, Pesenti A (1995) Alterations of lung and chest wall mechanics in patients
with acute lung injury: effects of positive end-expiratory pressure. Am J Respir Crit Care Med 152(2):531–537
4. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz
C, Oliveira R, Takagaki TY, Ribeiro Carvalho CR (1998) Effect of a protective-ventilation strategy on mortality in the
acute respiratory distress syndrome. N Engl J Med 338(6):347–354
5. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F
et al (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302(17):1872–1879
6. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A, Gandia F, Carriedo D, Mosteiro F, Basaldua S,
Fernández RL, Kacmarek RM, Network ALIEN (2011) The ALIEN study: incidence and outcome of acute respiratory
distress syndrome in the era of lung protective ventilation. Intensive Care Med 37(12):1932–1941
7. Bellani G, Guerra L, Musch G, Zanella A, Patroniti N, Mauri T, Messa C, Pesenti A (2011) Lung regional metabolic
activity and gas volume changes induced by tidal ventilation in patients with acute lung injury. Am J Respir Crit
Care Med 183(9):1193–1199
8. Estenssoro E, Dubin A, Laffaire E, Canales H, Saenz G, Moseinco M, Pozo M, Gomez A, Baredes N, Jannello G,
Osatnik J (2002) Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome.
Crit Care Med 30(11):2450–2456
9. Hess DR, Fink JB, Venkataraman ST, Kim IK, Myers TR, Tano BD (2006) The history and physics of heliox. Respir Care
51(6):608–612
10. Frazier MD, Cheifetz IM (2010) The role of heliox in paediatric respiratory disease. Paediatr Respir Rev 11(1):46–53,
quiz 53
11. Venkataraman ST (2006) Heliox during mechanical ventilation. Respir Care 51(6):632–639
12. Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM (2003) Helium-oxygen therapy for pediatric acute severe
asthma requiring mechanical ventilation. Pediatr Crit Care Med 4(3):353–357
13. Siddappa R, Dowhy MS, Rotta AT, Hernan LJ, Fuhrman BP (2005) Low bias flow oscillation with heliox in oleic
acid-induced lung injury. Pediatr Crit Care Med 6(1):70–75
14. Nawab US, Touch SM, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR (2005) Heliox
attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol 40(6):524–532
15. Katz A, Gentile MA, Craig DM, Quick G, Meliones JN, Cheifetz IM (2001) Heliox improves gas exchange during
high-frequency ventilation in a pediatric model of acute lung injury. Am J Respir Crit Care Med 164(2):260–264
16. Beurskens C, Brevoord D, Horn J, Preckel B, Vroom M, Juffermans N (2012) Heliox ventilation improves ventilation
in patients with induced hypothermia. Am J Respir Crit Care Med 185(1 Meeting Abstracts):A1718
17. Beurskens CJ, Aslami H, de Beer FM, Vroom MB, Preckel B, Horn J, Juffermans NP (2013) Heliox allows for lower
minute volume ventilation in an animal model of ventilator-induced lung injury. PLoS One 8(10):e78159
18. Yilmaz S, Daglioglu K, Yildizdas D, Bayram I, Gumurdulu D, Polat S (2013) The effectiveness of heliox in acute
respiratory distress syndrome. Ann Thorac Med 8(1):46–52
Beurskens et al. Intensive Care Medicine Experimental 2014, 2:8 Page 9 of 9
http://www.icm-experimental.com/content/2/1/819. Aslami H, Beurskens CJ, de Beer FM, Kuipers MT, Roelofs JJ, Hegeman MA, Van der Sluijs KF, Schultz MJ,
Juffermans NP (2013) A short course of infusion of a hydrogen sulfide-donor attenuates endotoxemia induced
organ injury via stimulation of anti-inflammatory pathways, with no additional protection from prolonged infusion.
Cytokine 61(2):614–621
20. Aslami H, Kuipers MT, Beurskens CJ, Roelofs JJ, Schultz MJ, Juffermans NP (2012) Mild hypothermia reduces
ventilator-induced lung injury, irrespective of reducing respiratory rate. Transl Res 159(2):110–117
21. Hegeman MA, Hemmes SN, Kuipers MT, Bos LD, Jongsma G, Roelofs JJ, van der Sluijs KF, Juffermans NP, Vroom
MB, Schultz MJ (2013) The extent of ventilator-induced lung injury in mice partly depends on duration of
mechanical ventilation. Crit Care Res Pract 2013:435236
22. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM (2011) An official
American thoracic society workshop report: features and measurements of experimental acute lung injury in
animals. Am J Respir Cell Mol Biol 44(5):725–738
23. Katz AL, Gentile MA, Craig DM, Quick G, Cheifetz IM (2003) Heliox does not affect gas exchange during high-
frequency oscillatory ventilation if tidal volume is held constant. Crit Care Med 31(7):2006–2009
24. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G, Herrmann P, Mascia L, Quintel M,
Slutsky AS, Gattinoni L, Ranieri VM (2007) Tidal hyperinflation during low tidal volume ventilation in acute
respiratory distress syndrome. Am J Respir Crit Care Med 175(2):160–166
25. Hager DN, Krishnan JA, Hayden DL, Brower RG, ACTN (2005) Tidal volume reduction in patients with acute lung
injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245
26. Bein T, Weber-Carstens S, Goldmann A, Muller T, Staudinger T, Brederlau J, Muellenbach R, Dembinski R, Graf BM,
Wewalka M, Philipp A, Wernecke KD, Lubnow M, Slutsky AS (2013) Lower tidal volume strategy (≈3 ml/kg)
combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS:
the prospective randomized Xtravent-study. Intensive Care Med 39(5):847–856
27. Kneyber MC, van Heerde M, Twisk JW, Plotz FB, Markhors DG (2009) Heliox reduces respiratory system resistance
in respiratory syncytial virus induced respiratory failure. Crit Care 13(3):R71
28. Chevrolet JC (2001) Helium oxygen mixtures in the intensive care unit. Crit Care 5(4):179–181
29. Gainnier M, Forel JM (2006) Clinical review: use of helium-oxygen in critically ill patients. Crit Care 10(6):241
30. Martin AR, Katz IM, Jenofi K, Caillibotte G, Brochard L, Texereau J (2012) Bench experiments comparing simulated
inspiratory effort when breathing helium-oxygen mixtures to that during positive pressure support with air. BMC
Pulm Med 12:62
31. Lucchinetti E, Wacker J, Maurer C, Keel M, Harter L, Zaugg K, Zaugg M (2009) Helium breathing provides modest
antiinflammatory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Anesth
Analg 109(1):101–108
32. Oei GT, Weber NC, Hollmann MW, Preckel B (2010) Cellular effects of helium in different organs. Anesthesiology
112(6):1503–1510doi:10.1186/2197-425X-2-8
Cite this article as: Beurskens et al.: Mechanical ventilation with heliox in an animal model of acute respiratory
distress syndrome. Intensive Care Medicine Experimental 2014 2:8.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
